rediff.com
e.g. Tata motors, Reliance MF, 500570
BSE | NSE

GlaxoSmithKline Pharmaceuticals Ltd.

500660 GLAXO Group (A)

01 Nov,18:59
2723.20
3.40 (0.13%)
HOW HOT IS THIS STOCK?

Last 15 days data © Rediff.com

Add to Watchlist
 
Refresh
Zoom
Day
Wk
Mn
6Mn
Yr
Volume Prev close Day's H/L (Rs.) 52wk H/L (Rs.) Mkt Cap (Rs. Cr)

GlaxoSmithKline Pharmaceuticals Ltd.

BUYSELL
1,062 2,719.80 2,746.15 - 2,719.85 3,087.95 - 1,387.90 46,131.01
NSE | BSE

GlaxoSmithKline Pharmaceuticals Ltd.

GLAXO

01 Nov,19:19
2733.10
20.85 (0.77%)
HOW HOT IS THIS STOCK?

Last 15 days data © Rediff.com

Add to Watchlist
 
Refresh
Zoom
Day
Wk
Mn
6Mn
Yr
Volume Prev close Day's H/L (Rs.) 52wk H/L (Rs.) Turnover (Rs. Lacs)

GlaxoSmithKline Pharmaceuticals Ltd.

BUYSELL
6,923 2712.25 2,742.95 - 2,721.10 3,088.00 - 1,385.05 189.33
(Rs. Crore)

Financial Results of GlaxoSmithKline Pharmaceuticals Ltd.

Mar ' 24Mar ' 23Mar ' 22Mar ' 21Mar ' 20
Sales3,407.253,216.343,217.513,193.733,224.68
Operating profit900.65799.41755.83694.95658.45
Interest1.801.811.993.536.34
Gross profit1,022.33899.12830.06801.61729.67
EPS (Rs)34.5135.8799.7921.116.50

See more in Research Center »

Statements:Balance Sheet  |  P&L  |  Cash Flow
More:Dividend  |  Bonus  |  Share Holding  |  Capital Structures  |  Ratios

About GlaxoSmithKline Pharmaceuticals Ltd.

GlaxoSmithKline Pharmaceuticals Ltd is an Indian research-based pharmaceutical and healthcare company, and a subsidiary of GSK. The company's product portfolio includes prescription medicines and vaccines. Its prescription medicines range across therapeutic areas such as anti-infectives, dermatology, gynaecology, diabetes, oncology, cardiovascular disease, and respiratory diseases. It also offers a range of vaccines, for the prevention of hepatitis A, hepatitis B, invasive disease caused by H, influenzae, chickenpox, diphtheria, pertussis, tetanus, rotavirus, cervical cancer, and others. Wikipedia

News for Pharmaceuticals and health care

Coal India Aims...
Coal India Aims for Dividend Return by FY'26
Coal India aims to eliminate ECL's losses and rejoin the dividend list by FY'26, with subsidiary Bharat Coking Coal already achieving this. The company also plans to boost production and reduce...
Nov 03, 2024 19:01
Gold Poised for...
Gold Poised for 15-18% Returns in Samvat 2081: Analysts
Analysts predict a strong 15-18% return for gold in Samvat 2081, driven by positive economic factors and safe-haven demand. Learn about the outlook for gold and silver in the new financial year.
Nov 03, 2024 18:31
Punjab Paddy...
Punjab Paddy Procurement Crosses 85 Lakh Tonnes: Centre
Punjab has procured 85.41 lakh tonnes of paddy in the 2024-25 kharif marketing season, with procurement operations now in full swing. The Centre has fixed a target of 185 LT for the state.
Nov 03, 2024 17:15
Microsoft Sees No...
Microsoft Sees No Tech Spend Slowdown in India, AI, Copilot Driving Growth
Microsoft India President Puneet Chandok highlights strong tech spending in India, driven by AI and Copilot adoption, and emphasizes the company's commitment to responsible AI development.
Nov 03, 2024 16:56
Sebi Fines Sunil...
Sebi Fines Sunil Lulla Rs 50 Lakh for Market Norm Violations
Sebi has imposed a Rs 50 lakh fine on Sunil Lulla, former MD of Eros International, for violating market norms in a case related to possible fund diversion. The regulator found Lulla non-compliant...
Nov 03, 2024 16:15

More News »

Top News

Coal India Aims...
Coal India Aims for Dividend Return by FY'26
Coal India aims to eliminate ECL's losses and rejoin the dividend list by FY'26, with subsidiary Bharat Coking Coal already achieving this. The company also plans to boost production and reduce...
Nov 03, 2024 19:01
Gold Poised for...
Gold Poised for 15-18% Returns in Samvat 2081: Analysts
Analysts predict a strong 15-18% return for gold in Samvat 2081, driven by positive economic factors and safe-haven demand. Learn about the outlook for gold and silver in the new financial year.
Nov 03, 2024 18:31
Punjab Paddy...
Punjab Paddy Procurement Crosses 85 Lakh Tonnes: Centre
Punjab has procured 85.41 lakh tonnes of paddy in the 2024-25 kharif marketing season, with procurement operations now in full swing. The Centre has fixed a target of 185 LT for the state.
Nov 03, 2024 17:15
Microsoft Sees No...
Microsoft Sees No Tech Spend Slowdown in India, AI, Copilot Driving Growth
Microsoft India President Puneet Chandok highlights strong tech spending in India, driven by AI and Copilot adoption, and emphasizes the company's commitment to responsible AI development.
Nov 03, 2024 16:56
Business School Applications Surge Despite Economic Uncertainty
Applications for business school graduate programmes soared 12% in 2024, driven by renewed interest in full-time, in-person offerings and increased financial aid.
Nov 03, 2024 16:44

More Top News »

Report Card

PE Ratios
78.90
EPS (Rs.)
34.51
Sales (Rs. Cr)
1,000.05
Face Value (Rs.)
10
Net Profit Margin (%)
17.16
Last Bonus
1:1
Last Dividend(%)
120
Return on Average Equity
32.6

BSE Announcements from GlaxoSmithKline Pharmaceuticals Ltd. (See all)

announcement Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate - 4 day(s) ago
announcement Outcome Of Meeting - 4 day(s) ago

Compare 'GlaxoSmithKline Pharmaceuticals Ltd.' with other stocks

  • Sun Pharmaceutical Industries Ltd.
  • 1,849.05
  • Compare
  • Torrent Pharmaceuticals Ltd.
  • 3,202.15
  • Compare
  • Zydus Lifesciences Ltd.
  • 1,001.85
  • Compare
  • Apollo Hospitals Enterprise Ltd.
  • 7,020.70
  • Compare
  • Max Healthcare Institute Ltd.
  • 1,016.65
  • Compare
  • Divi's Laboratories Ltd.
  • 5,893.90
  • Compare
  • Alkem Laboratories Ltd.
  • 5,783.95
  • Compare

Mutual Funds Invested

Most Active

  • Change (Rs.)
  •  

REDIFFGURUS

I have received a property in blood relation from my...

My husband is 50 and I am 47. We have a combined...

I am sixty three and retired . I have 1 cr in...

sir,A Doctor running a two hospitals . 2 nd hospital...

Hello Col.I am 34 years old, monthly salary is 1...

I am 51 yrs old with 6Cr in equities, 70 lakhs in...

More REDIFFGURUS

RediffGurus

Money question

I want to invest 6 lakh per month in SIP. I have...

GlaxoSmithKline Pharmaceuticals Ltd. performance snapshot

If you had invested Rs.  in GlaxoSmithKline Pharmaceuticals Ltd.,     ago

You would have  Rs. 000.00 

Add to Portfolio
GlaxoSmithKline Pharmaceuticals Ltd.
Share Price » Fundamentals » Financial » Technicals » Screener » Open Demat »

Peers

  • LTP
  • Change (Rs.)
  • Change %
  • Mkt Cap (Rs. Cr)
  • Volume

ALL MONEYWIZ PAGES

rediff on the net© 2024 Rediff.com India Limited. All rights reserved. Disclaimer - Terms of Service - Privacy Policy - Feedback
Close
Add GlaxoSmithKline Pharmaceuticals Ltd. to your Portfolio
 
 
BSE NSE  
 
Close
Add GlaxoSmithKline Pharmaceuticals Ltd. to your Watchlist
Alert me if price...
*Watchlist will be based on BSE values
Close